Abstract
Lupus podocytopathy (LP) is an uncommon proteinuric disorder in the spectrum of lupus nephropathy. Its histological features are similar to those described in minimal change disease (MCD) with or without mesangial immune deposits. Although infrequent, a close relationship between systemic lupus erythematosus (SLE) and thrombotic thrombocytopenic purpura (TTP) is well accepted. Proteinuria in the setting of SLE has previously been associated with the development of TTP-like syndrome. As far as we know, LP first presenting as a TTP-like syndrome has never been reported. Here, we describe the case of a previously healthy 45-year-old woman who developed simultaneously these two conditions and then we briefly review the literature on the topic, emphasizing the previous cases of concurrent initial diagnosis of both SLE and MCD (n = 7) and SLE and TTP (n = 72). In conclusion, renal biopsy is central to the management of SLE patients with nephrotic syndrome. Furthermore, in a SLE patient with anemia and thrombocytopenia, TTP should be part of the differential diagnosis, even when no schistocytes were detected in peripheral blood smear.
Similar content being viewed by others
References
Lewis EJ (2010) Lupus podocytopathy. In: Lupus Nephritis. Oxford University Press, Oxford, pp 199–210
Mok CC, Cheung TT, Lo WH (2010) Minimal mesangial lupus nephritis: a systematic review. Scand J Rheumatol 39(3):181–189
Matsuyama T, Kuwana M, Matsumoto M, Isonishi A, Inokuma S, Fujimura Y (2009) Heterogeneous pathogenic processes of thrombotic microangiopathies in patients with connective tissue diseases. Thromb Haemost 102(2):371–378
Jiang H, An X, Li Y, Sun Y, Shen G, Tu Y, Tao J (2014) Clinical features and prognostic factors of thrombotic thrombocytopenic purpura associated with systemic lupus erythematosus: a literature review of 105 cases from 1999 to 2011. Clin Rheumatol 33(3):419–427
Hunt BJ, Tueger S, Pattison J, Cavenagh J, D’Cruz DP (2007) Microangiopathic haemolytic anaemia secondary to lupus nephritis: an important differential diagnosis of thrombotic thrombocytopenic purpura. Lupus 16(5):358–362
Wang Y, Yu F, Song D, Wang SX, Zhao MH (2014) Podocyte involvement in lupus nephritis based on the 2003 ISN/RPS system: a large cohort study from a single centre. Rheumatology (Oxford) 53(7):1235–1244
Matsumura N, Dohi K, Shiiki H, Morita H, Yamada H, Fujimoto J et al (1989) Three cases presenting with systemic lupus erythematosus and minimal change nephrotic syndrome. Nihon Jinzo Gakkai Shi 31(9):991–999
Guery B, Martinez F, Beaufils H, Deray G (1997) Minimal-change nephropathy associated with systemic lupus erythematosus. Nephrol Dial Transplant 12(9):2030–2031
Seo DB, Lee SW, Song JH, Lee KJ, Han JY, Kim MJ (2002) Acute renal failure associated with a minimal change nephrotic syndrome in a systemic lupus erythematosus patient. Yonsei Med J 43(1):114–118
Hertig A, Droz D, Lesavre P, Grünfeld JP, Rieu P (2002) SLE and idiopathic nephrotic syndrome: coincidence or not? Am J Kidney Dis 40(6):1179–1184
Hsieh RY, Wu AB, Chang YT, Cheng MF, Wein-Chung Chen WC, Huang JJ (2007) Minimal change nephrotic syndrome in two patients with suspected systemic lupus erythematosus: association or co-incidence. Acta Nephrologica 21(1):52–57
Moysés-Neto M, Costa RS, Rodrigues FF, Vieira Neto OM, Reis MA, Louzada Júnior P et al (2011) Minimal change disease: a variant of lupus nephritis. NDT Plus 4(1):20–22
Shahane A, Khasnis A, Gota C (2012) Rituximab-responsive nephrotic syndrome due to minimal change disease in systemic lupus erythematosus. J Clin Rheumatol 18(4):199–202
Hu WX, Chen YH, Bao H, Liu ZZ, Wang SF, Zhang HT, Liu ZH (2015) Glucocorticoid with or without additional immunosuppressant therapy for patients with lupus podocytopathy: a retrospective single-center study. Lupus 24:1067–75. doi:10.1177/0961203315578766
Dube GK, Markowitz GS, Radhakrishnan J, Appel GB, D’Agati VD (2002) Minimal change disease in systemic lupus erythematosus. Clin Nephrol 57(2):120–126
Harirforoosh S, Jamali F (2009) Renal adverse effects of nonsteroidal anti-inflammatory drugs. Expert Opin Drug Saf 8(6):669–681
Whelton A (1999) Nephrotoxicity of nonsteroidal anti-inflammatory drugs: physiologic foundations and clinical implications. Am J Med 106(5B):13S–24S
Wang YT, Chou HH, Chen FF, Chen MJ, Chiou YY (2006) A case of minimal-change nephrotic syndrome in pediatric lupus erythematosus: just a coincidence? Lupus 15(4):244–247
Klonizakis P, Tselios K, Sarantopoulos A, Gougourellas I, Rouka E, Onufriadou Z et al (2013) ADAMTS-13 metalloprotease abnormalities in systemic lupus erythematosus: is there a correlation with disease status? Lupus 22(5):443–452
Dold S, Singh R, Sarwar H, Menon Y, Candia L, Espinoza LR (2005) Frequency of microangiopathic hemolytic anemia in patients with systemic lupus erythematosus exacerbation: distinction from thrombotic thrombocytopenic purpura, prognosis, and outcome. Arthritis Rheum 53(6):982–985
Lansigan F, Isufi I, Tagoe CE (2011) Microangiopathic haemolytic anaemia resembling thrombotic thrombocytopenic purpura in systemic lupus erythematosus: the role of ADAMTS13. Rheumatology (Oxford) 50(5):824–829
Merayo-Chalico J, Demichelis-Gómez R, Rajme-López S, Aparicio-Vera L, Barrera-Vargas A, Alcocer-Varela J et al (2014) Risk factors and clinical profile of thrombotic thrombocytopenic purpura in systemic lupus erythematosus patients. Is this a distinctive clinical entity in the thrombotic microangiopathy spectrum?: a case control study. Thromb Res 134(5):1020–1027
Musio F, Bohen EM, Yuan CM, Welch PG (1998) Review of thrombotic thrombocytopenic purpura in the setting of systemic lupus erythematosus. Semin Arthritis Rheum 28(1):1–19
El Khayat SS, Medkouri G, Etomba AM, Zamd M, Gharbi MB, Ramadani B (2012) Thrombotic thrombocytopenic purpura and systemic lupus erythematosus: a rare and life-threatening association. Arab J Nephrol Transplant 5(2):103–105
George JN, Chen Q, Deford CC, Al-Nouri Z (2012) Ten patient stories illustrating the extraordinarily diverse clinical features of patients with thrombotic thrombocytopenic purpura and severe ADAMTS13 deficiency. J Clin Apher 27(6):302–311
Campos LM, Spadoni MS, Michelin CM, Jesus AA, Carneiro JD, da Silva CA (2013) Thrombotic thrombocytopenic purpura at presentation of juvenile systemic lupus erythematosus patients. Rev Bras Reumatol 53(1):120–126
Cui J, Zhu TN, Zhao YQ, Zhang FC (2013) The clinical analysis of 14 cases of systemic lupus erythematosus complicated by thrombotic thrombocytopenic purpura. Zhonghua Nei Ke Za Zhi 52(5):383–386
Palaniappan P, Lionel AP, Agarwal I, Mathai S, Mathew L, Agarwal S et al (2014) Cryosupernatant and immunosuppression as effective alternative therapies for TTP in three pediatric SLE patients. Indian J Hematol Blood Transfus 30(Suppl 1):232–236
Hassan ATA, Elbadry MIY, Tawfik MA (2014) A case report of thrombotic thrombocytopenic purpura associated with systemic lupus erythematosus: overlapping features. Am J Med Case Rep 2(10):206–213
Changcharoen B, Bolger DT Jr (2015) Thrombotic thrombocytopenic purpura as an initial presentation of systemic lupus erythematosus with acquired ADAMTS 13 antibody. BMJ Case Rep 20:2015
Prasun Giri P, Sinha R, Pal P, Sarkar B (2015) Therapeutic plasma exchange in paediatric SLE: a case series from India. Lupus 24(8):889–891
Song D, Wu LH, Wang FM, Yang XW, Zhu D, Chen M et al (2013) The spectrum of renal thrombotic microangiopathy in lupus nephritis. Arthritis Res Ther 15(1):R12
Zini G, d’Onofrio G, Briggs C, Erber W, Jou JM, Lee SH et al (2012) ICSH recommendations for identification, diagnostic value, and quantitation of schistocytes. Int J Lab Hematol 34(2):107–116
Oregel KZ, Ramdial J, Glück S (2013) Nonsteroidal anti-inflammatory drug induced thrombotic thrombocytopenic purpura. Clin Med Insights Blood Disord 6:19–22
Hay SN, Egan JA, Millward PA, Bandarenko N, Brecher ME (2006) Patterns of platelet response in idiopathic TTP/HUS: frequency of declining platelet counts with plasma exchange and the recognition and significance of a pseudo refractory state. Ther Apher Dial 10(3):237–241
Tovoli F, De Giorgio R, Fabbri A et al (2011) Thrombotic thrombocytopenic purpura mimicking an acute meningoencephalitis. Acta Clin Belg 66(1):55–56
Nafil H, Tazi I, Mahmal L (2012) Purpura thrombotique thrombocytopénique (PTT) simulant une méningo-encéphalite. Rev Neurol (Paris) 168(11):873–874
Bortoluzzi A, Scirè CA, Bombardieri S, Caniatti L, Conti F, De Vita S et al (2015) Development and validation of a new algorithm for attribution of neuropsychiatric events in systemic lupus erythematosus. Rheumatology (Oxford) 54(5):891–898
Morís G, García-Moncó JC (2014) Drug-induced aseptic meningitis and other mimics. In: CNS infections. Springer, London, pp 249–271
Weksler BB, Lehany AM (1991) Naproxen-induced recurrent aseptic meningitis. DICP 25(11):1183–1184
Gao H, Li C, Mu R, Guo YQ, Liu T, Chen S et al (2011) Subclinical hypothyroidism and its association with lupus nephritis: a case control study in a large cohort of Chinese systemic lupus erythematosus patients. Lupus 20(10):1035–1041
Shen L, Lu G, Dong N, Ma Z, Ruan C (2013) Simvastatin increases ADAMTS13 expression in podocytes. Thromb Res 132(1):94–99
Thomas MR, McDonald V, Machin SJ, Scully MA (2011) Thrombotic thrombocytopenic purpura associated with statin therapy. Blood Coagul Fibrinolysis 22(8):762–763
Disclosures
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Delgado-García, G., Cámara-Lemarroy, C., Infante-Valenzuela, A. et al. Pure lupus podocytopathy first presenting as thrombotic thrombocytopenic purpura-like syndrome. Clin Rheumatol 35, 2131–2136 (2016). https://doi.org/10.1007/s10067-015-3069-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-015-3069-9